Biological Actions and Metabolism of Currently Used Pharmacological Agents for the Treatment of Congestive Heart Failure

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|3|206-219

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.3, 2009-03, pp. : 206-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Congestive Heart Failure: Pharmacological Agents and the Potential of BType Natriuretic Peptide

By  

Current Medicinal Chemistry, Vol. 12, Iss. 12, 2005-06 ,pp. : 1439-1447

Bentham Science Publishers

Access to resources Recommend Favorite

Nesiritide for the treatment of congestive heart failure

By Iyengar Srinivas   Feldman David S   Trupp Robin   Abraham William T  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 901-907

Informa Healthcare

Access to resources Recommend Favorite

Perindopril: In Congestive Heart Failure

By Simpson D.   Noble S.   Goa K.L.  

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1367-1377

Adis International

Access to resources Recommend Favorite

Bisoprolol for congestive heart failure

By Rosenberg Jens   Gustafsson Finn  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 293-300

Informa Healthcare

Access to resources Recommend Favorite

Editorial: Tumour Necrosis Factor As a Potential Target for the Treatment of Congestive Heart Failure

By Visioli F.  

Pharmacological Research, Vol. 40, Iss. 2, 1999-08 ,pp. : 91-91

Academic Press

Access to resources Recommend Favorite